FIELD: medicine, cardiology, endocrinology, gynecology.
SUBSTANCE: one should detect informational-valuable signs of patient's state, such as either the presence or absence of hypertonic disease and uterine extirpation together with adnexa, the value of body weight index, predominance of disorders according to modified menopausal index (MMI)such as autonomic, metabolic-endocrine or psycho-emotional ones, the type of metabolic structures of blood serum, moreover, it is necessary to echocardiographically detect stroke volume, cardiac index and systemic vascular resistance (SVR), at ultrasound testing one should detect maximal linear rate of circulation (LRC max) by medial cerebral artery and thyroid alterations, rheovasographically one should detect specific circulation (SC) of shins, at testing laser doppler flowmetry one should detect microcirculation index, biochemically it is necessary to detect the value of beta-adrenoreactivity, cholesterol level and that of B-lipoproteides, crystallographically - the presence of serotonin and dopamine crystals, due to immunoenzymatic assay on should detect the values by Table 1 and then after obtaining the values of diagnostic coefficients of every parameter it is necessary to summarize them and obtain diagnostic index (DI), at its value being below 10 one should state no alteration, at its value 10-10 - undetermined state, at its value being 21-30 - the 2nd severity degree of disorders, and at DI value being above 31 one should state the 3d severity degree of disorders available.
EFFECT: higher accuracy of evaluation.
5 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
METHOD OF ESTIMATING SEVERITY OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2536294C1 |
METHOD FOR EVALUATING INITIAL STAGES OF HEART FAILURE SEVERITY DEGREE | 2002 |
|
RU2223030C2 |
METHOD OF PREDICTING RISK OF METABOLIC SYNDROME DEVELOPMENT IN WOMEN OF PERIMENOPAUSE AGE | 2009 |
|
RU2396912C1 |
METHOD OF ASSESSING AGE-RELATED CHANGES OF HUMAN CARDIOVASCULAR SYSTEM | 2012 |
|
RU2485886C1 |
METHOD FOR PREDICTING CLINICAL EFFECTIVENESS OF CLIMACTERIC SYNDROME MELATONIN IN FEMALES IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN | 2019 |
|
RU2723764C1 |
METHOD FOR DETECTING HYPERDOPANEMIA AND HYPERSEROTONEMIA | 2000 |
|
RU2187110C2 |
METHOD FOR PREDICTION OF CARDIOVASCULAR DISORDERS ACCOMPANYING EARLY ADAPTATION IN INFANTS OF MOTHERS SUFFERING ARTERIAL HYPERTENSION | 2012 |
|
RU2478205C1 |
METHOD TO PREDICT HUMAN BODY ADAPTATION AT MIDDLE AND ELDERLY AGE | 1994 |
|
RU2113166C1 |
METHOD OF TREATING CLIMACTERIC SYNDROME IN PREMENOPAUSAL FEMALES | 2014 |
|
RU2564088C1 |
Authors
Dates
2005-05-20—Published
2003-08-18—Filed